Abstract
1. Myricetin is a natural bioflavonoid whose occurrence in nature is widespread among plants. 2. It has been demonstrated to possess both antioxidative properties and prooxidative properties. 3. It is a potent anticarcinogen and antimutagen, although it has been shown to promote mutagenesis with the use of the Ames Test. 4. Its therapeutic potential and benefits in cardiovascular diseases and diabetes mellitus also are reviewed.
MeSH terms
-
Animals
-
Anticarcinogenic Agents / pharmacology
-
Antioxidants / pharmacology
-
Antiviral Agents / pharmacology
-
Arteriosclerosis / drug therapy
-
DNA / drug effects
-
DNA Repair / drug effects
-
DNA Replication / drug effects
-
Flavonoids / pharmacology*
-
Flavonoids / therapeutic use
-
Humans
-
Hypoglycemic Agents / pharmacology
-
Mutagens / pharmacology
-
Reactive Oxygen Species
-
Thrombosis / drug therapy
Substances
-
Anticarcinogenic Agents
-
Antioxidants
-
Antiviral Agents
-
Flavonoids
-
Hypoglycemic Agents
-
Mutagens
-
Reactive Oxygen Species
-
myricetin
-
DNA